Gkv Capital Management Co., Inc. Biogen Inc. Transaction History
Gkv Capital Management Co., Inc.
- $120 Billion
- Q1 2025
A detailed history of Gkv Capital Management Co., Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 33 shares of BIIB stock, worth $4,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33Holding current value
$4,144% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,024Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.14 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.83 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$929 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$587 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...